Posts tagged Keryx Biopharmaceuticals


Keryx Biopharmaceuticals: This Analyst Blames Slowing Script Growth for Bad Q3 Outcome

Keryx Biopharmaceuticals (NASDAQ:KERX) has commercial adoption challenges ahead for its iron deficiency anemia asset Auryxia, …

Keryx Biopharmaceuticals (KERX): Focusing On Auryxia Growth

Maxim analyst Jason McCarthy is out today with a new research note on shares of Keryx Biopharmaceuticals …

Keryx Biopharmaceuticals (KERX) Reports 4Q and Full Year 2016 Results

Keryx Biopharmaceuticals (NASDAQ:KERX) announced its financial results for the fourth quarter and year ended December …

Company Update (NASDAQ:KERX): Keryx Biopharmaceuticals Announces Publication of Auryxia Phase 3 Trial Results in JASN

Keryx Biopharmaceuticals (NASDAQ:KERX) announced the publication of results from its pivotal Phase 3 study evaluating …

Company Update (NASDAQ:KERX): Keryx Biopharmaceuticals Announces Case Study Data of Auryxia® Presented at ASN’s Kidney Week

Keryx Biopharmaceuticals (NASDAQ:KERX) announced case study data, which showed that Auryxia® (ferric citrate) lowered and …

FBR Weighs in on Keryx Biopharmaceuticals (KERX) as FDA Approves Second CMO for Auryxia

FBR Capital analyst Christopher James weighed in with a few insights on Keryx Biopharmaceuticals (NASDAQ:KERX), after the …

Company Update (NASDAQ:KERX): Here’s Why Keryx Biopharmaceuticals Shares Rose 12% Today

Keryx Biopharmaceuticals (NASDAQ:KERX) investors have a smile on their faces Wednesday, after the drug maker …